A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.117.245027
Full Text
Open PDFAbstract
Available in full text
Date
December 20, 2017
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)